Elisabeth M. German

Elisabeth M. German serves as an Acquisition Administrator at the Naval Health Research Center (N63116), where she plays a pivotal role in executing mission-critical procurement strategies aligned with the Department of the Navy’s biomedical research objectives. She manages the full lifecycle of research and development contracts, ensuring timely acquisition of advanced medical technologies designed to enhance the health and operational readiness of Navy and Marine Corps personnel. Her portfolio centers on scientific innovation, including diagnostic tools, wearable biosensors, and pathogen detection systems, requiring close coordination with technical stakeholders to align procurement with evolving operational requirements and scientific milestones. While specific contractor relationships are not currently documented, her procurement patterns indicate a consistent engagement with research institutions, engineering firms, and life sciences vendors capable of delivering high-complexity, non-commercial solutions. She collaborates with vendors possessing deep expertise in biomedical engineering, clinical validation, and field-deployable diagnostics, fostering partnerships that prioritize technical rigor, rapid prototyping, and scalability for operational environments. Elisabeth’s contracting activity reflects a 100% non-set-aside orientation, indicating a primary focus on technical capability over socioeconomic classifications. This approach underscores a mission-driven priority to secure the most qualified performers for scientifically demanding projects, regardless of vendor size or certification status, while still adhering to all federal contracting regulations. Her primary procurement focus is on NAICS 541715—Research and Development in the Physical, Engineering, and Life Sciences—where she sources cutting-edge capabilities in infectious disease surveillance, physiological monitoring, and field-deployable medical diagnostics. She specializes in procuring proprietary technologies requiring rigorous validation, often involving human subject research, data analytics, and integration with military health systems, making her a key enabler of the Center’s mission to translate laboratory innovation into frontline medical readiness.